Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy-Reference-Cited by-同舟云学术

Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy

Published:1990-12 Issue:6 Volume:12 Page:1284-1289
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Takeda Kiyoshi,Akahane Yoshihiro,Suzuki Hiroshi,Okamoto Hiroaki,Tsuda Fumio,Miyakawa Yuzo,Mayumi Makoto

Publisher

Wiley

Subject

Hepatology

Reference29 articles.

1. Long-term Follow-up of Chronic Hepatitis Patients with HBsAg, HBeAg and Dane Particle Associated DIMA Polymerase in Serum

2. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

3. Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

4. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen

5. Recombinant leukocyte interferon treatment of chronic hepatitis B

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome analysis of hepatoma cells transfected with Basal Core Promoter (BCP) and Pre-Core (PC) mutant hepatitis B virus full genome construct;Journal of General Virology;2021-03-01

2. New perspective on the natural course of chronic HBV infection;Frontiers of Medicine;2014-05-29

3. Baseline and On-treatment Predictors of Chronic Hepatitis B Patients Receiving Pegylated Interferon Therapy in Asia;Current Hepatitis Reports;2013-06-18

4. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B;Hepatology;2012-04-25

5. Retrospective characterization of the S open reading frame of HBV isolated from children with membranous nephropathy treated with interferon-α2b;Antiviral Therapy;2010